Fintel reports that on April 8, 2025, William Blair initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Outperform recommendation. As of April 2, 2025, the average one-year price ...

Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform recommendation. As of February 19, 2025, the average one-year price ...

NYSE:SVV opened at $7.59 on Friday. Savers Value Village has a 12 month low of $6.48 and a 12 month high of $18.93. The company has a current ratio of 1.04, a quick ratio of 0.86 and a debt-to ...

Cell therapy developer CARGO Therapeutics (NASDAQ:CRGX) traded higher on Tuesday after William Blair launched its coverage with ... “We believe near-term initiatives to expand CAR-T access ...

William Blair analyst Andrew Brackmann initiated coverage of Butterfly Network (BFLY) with an Outperform rating. Easily identify stocks' risks and opportunities. Discover stocks' market position ...

Equities research analysts at William Blair began coverage on shares of Waste Connections (NYSE:WCN – Get Free Report) in a ...

William Blair sees room for margin expansion in fiscal 2027 as revenue growth accelerates, retention improves, and PLG initiatives gain traction. While macro sensitivity and competition remain ...

On Monday, William Blair reaffirmed a Market Perform rating ... sequential sales growth throughout the year. The company's initiatives, if successful, may set Kenvue on a course to reach its ...

Kennedy highlighted that since William Blair initiated coverage on Nayax ... These recent developments reflect Nayax’s strategic initiatives to expand its market presence and improve its ...